8-K
filed January 12, 2026, 6:59 PM ET
ticker BNGO
CIK 0001411690
earnings
confidence medium
sentiment neutral
materiality 0.50
Bionano reports preliminary Q4/FY 2025 revenue down 2-8% YoY; cash $29.6M
Bionano Genomics, Inc.
2025-FY EPS
reported -$4.85
vs consensus -$1.43
▼ miss
(-239.6%)
- Total Q4 revenue $7.8-8.0M, down 2-4% YoY; full-year $28.4-28.6M, down 7-8%.
- Installed 9 new OGM systems in Q4, 32 in FY; installed base at 387 systems at year-end.
- Cash, equivalents and restricted investments $29.6M as of Dec 31, 2025 ($10.3M restricted).
- Nanochannel array flowcells sold: 7,554 in Q4, 30,171 for full year 2025.
- Preliminary unaudited results; subject to change after year-end close and audit.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001140361-26-000904
- form_type
- 8-K
- ticker
- BNGO
- cik
- 0001411690
- company_name
- Bionano Genomics, Inc.
- filed_at
- 2026-01-12T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:35.021562+00:00
- generated_at
- 2026-05-16T10:49:19.876253+00:00
- sec_items
- ["2.02", "9.01"]
- event_type
- earnings
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- medium
- secwatch_canonical_url
- https://secwatch.observer/filing/0001140361-26-000904
- json_url
- https://secwatch.observer/filing/0001140361-26-000904.json
- markdown_url
- https://secwatch.observer/filing/0001140361-26-000904.md
- text_url
- https://secwatch.observer/filing/0001140361-26-000904.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1411690/000114036126000904/0001140361-26-000904-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1411690/000114036126000904/ef20062688_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
NTAP
NetApp reports Q4/FY2026 results (details not in filing) and adds $1B buyback
NetApp, Inc.
May 28, 2026, 4:05 PM ET
earnings
Items 2.02, 8.01, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
KSS
Kohl's Q1 net loss $14M; comparable sales down 1.1% YoY; affirms FY outlook
KOHLS Corp
May 28, 2026, 7:00 AM ET
earnings
Items 2.02, 7.01, 8.01, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
BRN
Barnwell Q2 net loss narrows to $0.09/share; revenue $2.535M
BARNWELL INDUSTRIES INC
May 26, 2026, 4:45 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
SCNX
SCIENTURE Q1 revenue $56k (+449% YoY); gross margin 95.6%; net loss $3.4M; secures $11M debt
Scienture Holdings, Inc.
May 22, 2026, 5:00 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
UWHR
Uwharrie Capital Q1 net income $3.2M, up 23% YoY; assets reach $1.25B
UWHARRIE CAPITAL CORP
May 22, 2026, 11:45 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
CPRT
Copart Q3 FY2026 EPS $0.43 (+2.4%); revenue $1.2B (+2.1%)
COPART INC
May 21, 2026, 4:16 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
GLTK
Globaltech Q1 revenue $10.4M (+142% YoY); net loss widens to $4.0M
GlobalTech Corp
May 21, 2026, 7:30 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
HLNE
Hamilton Lane reports FY2026 results; raises dividend 11% and expands buyback to $100M
Hamilton Lane INC
May 21, 2026, 7:00 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.